IOF vs. TET, SYNT, ZTF, WCH, ITX, DCTA, HAYD, HDD, VRS, and ESKN
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Zotefoams (ZTF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Haydale Graphene Industries (HAYD), Hardide (HDD), Versarien (VRS), and Esken (ESKN). These companies are all part of the "specialty chemicals" industry.
Iofina vs.
Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, earnings, risk, community ranking, dividends, media sentiment, institutional ownership, analyst recommendations and profitability.
Treatt currently has a consensus target price of GBX 650, indicating a potential upside of 94.22%. Iofina has a consensus target price of GBX 36.25, indicating a potential upside of 61.47%. Given Treatt's higher probable upside, analysts clearly believe Treatt is more favorable than Iofina.
Iofina received 35 more outperform votes than Treatt when rated by MarketBeat users. However, 68.97% of users gave Treatt an outperform vote while only 66.33% of users gave Iofina an outperform vote.
Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.
50.9% of Treatt shares are owned by institutional investors. Comparatively, 6.4% of Iofina shares are owned by institutional investors. 13.4% of Treatt shares are owned by insiders. Comparatively, 45.1% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Treatt had 1 more articles in the media than Iofina. MarketBeat recorded 3 mentions for Treatt and 2 mentions for Iofina. Iofina's average media sentiment score of 0.00 beat Treatt's score of -0.12 indicating that Iofina is being referred to more favorably in the news media.
Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.
Treatt has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.
Summary
Treatt beats Iofina on 13 of the 17 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IOF) was last updated on 3/28/2025 by MarketBeat.com Staff
